STRONGYLOIDIASIS TREATED WITH PYRVINIUM PAMOATE
Overview
Overview
Journal
JAMA
Publisher
American Medical Association
Specialty
General Medicine
Date
1965 Sep 6
PMID
14330001
Citations
2
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Pyrvinium Pamoate: Past, Present, and Future as an Anti-Cancer Drug.
Schultz C, Nevler A Biomedicines. 2022; 10(12).
PMID: 36552005 PMC: 9775650. DOI: 10.3390/biomedicines10123249.
Pyrvinium Pamoate and Structural Analogs Are Early Macrofilaricide Leads.
Gunderson E, Bryant C, Bulman C, Fischer C, Luo M, Vogel I Pharmaceuticals (Basel). 2022; 15(2).
PMID: 35215301 PMC: 8880385. DOI: 10.3390/ph15020189.